603108 XD润达医疗
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,661,846-19.81%8,311,7809,147,37310,494,4198,860,108
减:营业总成本1,695,370-12.97%7,994,7838,651,9939,643,2848,160,246
    其中:营业成本1,316,526-13.22%6,203,4926,718,3717,557,0676,468,094
               财务费用63,899-20.77%313,435316,682323,591291,634
               资产减值损失(70)-44.50%(36,170)(34,500)(40,772)(7,299)
公允价值变动收益------------
投资收益20,674-21.03%109,821231,999137,048137,876
    其中:对联营企业和合营企业的投资收益20,668-20.85%108,488139,609138,057133,628
营业利润(49,107)-158.74%354,060646,803816,373777,798
利润总额(48,726)-157.61%345,542655,555819,651780,456
减:所得税费用19,137-48.35%156,084212,920164,541182,255
净利润(67,863)-242.80%189,458442,636655,110598,201
减:非控股权益1,396-94.40%134,177169,339237,364217,972
股东净利润(69,259)-406.40%55,281273,296417,746380,229

市场价值指针
每股收益 (元) *-0.110-375.00%0.0900.4700.7200.660
每股派息 (元) *----0.0300.1000.150--
每股净资产 (元) *7.022-1.39%7.1367.0606.5195.785
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容